Evidence map›Paper›PMID 18497877›Full record

ArticleThe Journal of clinical investigation2008

HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice.

Toshio Hisatomi, Toru Nakazawa, Kousuke Noda, Lama Almulki, Shinsuke Miyahara, Shintaro Nakao, Yasuhiro Ito, Haicheng She, Riichiro Kohno, Norman Michaud and 5 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. AnFrontiers in neuroscience · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Toshio HisatomiAngiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114, USA.
Toru Nakazawa
Kousuke Noda
Lama Almulki
Shinsuke Miyahara
Shintaro Nakao
Yasuhiro Ito
Haicheng She
Riichiro Kohno
Norman Michaud
Tatsuro Ishibashi
Ali Hafezi-Moghadam
Andrew D Badley
Guido Kroemer
Joan W Miller
Harvard University Press · USKyushu University · JPInstitut National de Recherche en Santé Publique · MLMayo Clinic · US

Funding

P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Janey L Wiggs · 2002 to 2026
$15.1M
Procaspase 8 Activation by HIV ProteaseR01AI062261 · NIAID · MAYO CLINIC ROCHESTER · PI BADLEY, ANDREW D · 2004 to 2008
$1.5M
Mechanisms of Selectin Shedding in Leukocyte RecruitmentK08AI050775 · NIAID · MASSACHUSETTS EYE AND EAR INFIRMARY · PI HAFEZI-MOGHADAM, ALI · 2002 to 2004
$377k
NEI NIH HHS EY014104NEI NIH HHS P30 EY014104NIAID NIH HHS AI50775NIAID NIH HHS K08 AI050775NIAID NIH HHS R01 AI062261NIAID NIH HHS R01 AI403840NIAID NIH HHS R01 AI62261
6 · The paper itself

Abstract

Neuroprotection can be achieved by preventing apoptotic death of postmitotic cells. Apoptotic death can occur by either a caspase-dependent mechanism, involving cytochrome c, apoptosis protease-activating factor-1 (Apaf-1), and caspase-9, or a caspase-independent mechanism, involving apoptosis-inducing factor (AIF). HIV protease inhibitors (PIs) avert apoptosis in part by preventing mitochondrial outer membrane permeabilization (MOMP), but the precise mechanism by which they work is not known. Here, we evaluated the impact of the PIs in a mouse model of retinal detachment (RD) in vivo and in murine primary retinal cell cultures in vitro. Oral administration of the PIs nelfinavir and ritonavir significantly inhibited photoreceptor apoptosis, while preventing the translocation of AIF from mitochondria to the nucleus as well as the activation of caspase-9. RD-induced photoreceptor apoptosis was similarly inhibited in mice carrying hypomorphic mutations of the genes encoding AIF or Apaf-1. Nelfinavir attenuated apoptosis as well as mitochondrial release of AIF and cytochrome c, and subsequent activation of caspase-9 in vitro, in photoreceptor cultures exposed to starvation or monocyte chemoattractant protein-1-stimulated (MCP-1-stimulated) macrophages. Our results suggest that the MOMP inhibition by PIs involved interruption of both caspase-dependent and caspase-independent apoptosis pathways and that PIs may be clinically useful for the treatment of diseases caused by excessive apoptosis.

Indexed as

ApoptosisAnimalsCaspase 9Chemokine CCL2Cytochromes cHIV Protease InhibitorsHumansMiceMicroscopy, FluorescenceMitochondriaModels, BiologicalMutationNelfinavirNeuroprotective AgentsRetinaCaspase 9Chemokine CCL2Cytochromes cHIV Protease InhibitorsNelfinavirNeuroprotective Agents

Identifiers

PMID18497877
PMCPMC2391064
OpenAlexW2134240199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.